|
1
|
Chen W, Zheng R, Zeng H, Zhang S and He J:
Annual report on status of cancer in China, 2011. Chin J Cancer
Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li H: Modern esophageal surgery. People's
Military Medical Press; Beijing: pp. 331–332. 2004
|
|
3
|
Esophageal cancer, . Epidemiology,
pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol.
5:517–526. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Holmes RS and Vaughan TL: Epidemiology and
pathogenesis of esophageal cancer. Semin Radiat Oncol. 17:2–9.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li JS, Ying JM, Wang XW, Wang ZH, Tao Q
and Li LL: Promoter methylation of tumor suppressor genes in
esophageal squamous cell carcinoma. Chin J Cancer. 32:3–11. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng CP, Kuo IY, Alakus H, Frazer KA,
Harismendy O, Wang YC and Tseng VS: Network-based analysis
identifies epigenetic biomarkers of esophageal squamous cell
carcinoma progression. Bioinformatics. 30:3054–3061. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bernier I and Jollés P: Purification and
characterization of a basic 23 kDa cytosolic protein from bovine
brain. Biochim Biophys Acta. 790:174–181. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yeung K, Seitz T, Li S, Janosch P,
McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, et
al: Suppression of Raf-1 kinase activity and MAP kinase signalling
by RKIP. Nature. 401:173–177. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yeung KC, Rose DW, Dhillon AS, Yaros D,
Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolch W and Sedivy
JM: Raf kinase inhibitor protein interacts with NF-kappaB-inducing
kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol.
21:7207–7217. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deiss K, Kisker C, Lohse MJ and Lorenz K:
Raf kinase inhibitor protein (RKIP) dimer formation controls its
target switch from Raf1 to G protein-coupled receptor kinase (GRK)
2. J Biol Chem. 287:23407–23417. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Escara-Wilke J, Yeung K and Keller ET: Raf
kinase inhibitor protein (RKIP) in cancer. Cancer Metastasis Rev.
31:615–620. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fu Z, Smith PC, Zhang L, Rubin MA, Dunn
RL, Yao Z and Keller ET: Effects of raf kinase inhibitor protein
expression on suppression of prostate cancer metastasis. J Natl
Cancer Inst. 95:878–889. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao Z, Lu P, Zhang H, Xu H, Gao N, Li M
and Liu C: Nestin positively regulates the Wnt/β-catenin pathway
and the proliferation, survival and invasiveness of breast cancer
stem cells. Breast Cancer Res. 16:4082014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu C, Lu P, Lu Y, Xu H, Wang S and Chen
J: Clinical implications of metastatic lymph node ratio in gastric
cancer. BMC Cancer. 7:2002007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim HS, Won KY, Kim GY, Kim SC, Park YK
and Kim YW: Reduced expression of Raf-1 kinase inhibitory protein
predicts regional lymph node metastasis and shorter survival in
esophageal squamous cell carcinoma. Pathol Res Pract. 208:292–299.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao C, Pang L, Ren C and Ma T: Prognostic
value of raf kinase inhibitor protein in esophageal squamous cell
carcinoma. Pathol Oncol Res. 18:471–477. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Birner P, Jesch B, Schultheis A and
Schoppmann SF: RAF-kinase inhibitor protein (RKIP) downregulation
in esophageal cancer and its metastases. Clin Exp Metastasis.
29:551–559. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo W, Dong Z, Guo Y, Lin X, Chen Z, Kuang
G and Yang Z: Aberrant methylation and loss expression of RKIP is
associated with tumor progression and poor prognosis in gastric
cardia adenocarcinoma. Clin Exp Metastasis. 30:265–275. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li DX, Cai HY, Wang X, Feng YL and Cai SW:
Promoter methylation of Raf kinase inhibitory protein: A
significant prognostic indicator for patients with gastric
adenocarcinoma. Exp Ther Med. 8:844–850. 2014.PubMed/NCBI
|
|
20
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rice TW, Blackstone EH and Rusch VW: 7th
edition of the AJCC Cancer Staging Manual: Esophagus and
esophagogastric junction. Ann Surg Oncol. 17:1721–1724. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: A novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Glickman JF, Flynn J and Reich NO:
Purification and characterization of recombinant
baculovirus-expressed mouse DNA methyltransferase. Biochem Biophys
Res Commun. 230:280–284. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fromowitz FB, Viola MV, Chao S, Oravez S,
Mishriki Y, Finkel G, Grimson R and Lundy J: ras p21 expression in
the progression of breast cancer. Hum Pathol. 18:1268–1275. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Baylin SB: DNA methylation and gene
silencing in cancer. Nat Clin Pract Oncol. 2:(Suppl 1). S4–S11.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kulis M and Esteller M: DNA methylation
and cancer. Adv Genet. 70:27–56. 2010.PubMed/NCBI
|
|
27
|
Yang CS: Vitamin nutrition and
gastroesophageal cancer. J Nutr. 130:(Suppl 2S). S338–S339.
2000.
|
|
28
|
Yokokawa Y, Ohta S, Hou J, Zhang XL, Li
SS, Ping YM and Nakajima T: Ecological study on the risks of
esophageal cancer in Ci-Xian, China: The importance of nutritional
status and the use of well water. Int J Cancer. 83:620–624. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Launoy G, Milan CH, Faivre J, Pienkowski
P, Milan CI and Gignoux M: Alcohol, tobacco and oesophageal cancer:
Effects of the duration of consumption, mean intake and current and
former consumption. Br J Cancer. 75:1389–1396. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gao YB, Chen ZL, Li JG, Hu XD, Shi XJ, Sun
ZM, Zhang F, Zhao ZR, Li ZT, Liu ZY, et al: Genetic landscape of
esophageal squamous cell carcinoma. Nat Genet. 46:1097–1102. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sasaki Y, Tamura M, Koyama R, Nakagaki T,
Adachi Y and Tokino T: Genomic characterization of esophageal
squamous cell carcinoma: Insights from next-generation sequencing.
World J Gastroenterol. 22:2284–2293. 2016.PubMed/NCBI
|
|
32
|
Kailasam A, Mittal SK and Agrawal DK:
Epigenetics in the pathogenesis of esophageal adenocarcinoma. Clin
Transl Sci. 8:394–402. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma K, Cao B and Guo M: The detective,
prognostic, and predictive value of DNA methylation in human
esophageal squamous cell carcinoma. Clin Epigenetics. 8:432016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shames DS, Minna JD and Gazdar AF: DNA
methylation in health, disease, and cancer. Curr Mol Med. 7:85–102.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jones PA, Rideout WM III, Shen JC, Spruck
CH and Tsai YC: Methylation, mutation and cancer. Bioessays.
14:33–36. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pogribny I, Raiche J, Slovack M and
Kovalchuk O: Dose-dependence, sex- and tissue-specificity, and
persistence of radiation-induced genomic DNA methylation changes.
Biochem Biophys Res Commun. 320:1253–1261. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brooks JD, Weinstein M, Lin X, Sun Y, Pin
SS, Bova GS, Epstein JI, Isaacs WB and Nelson WG: CG island
methylation changes near the GSTP1 gene in prostatic
intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev.
7:531–536. 1998.PubMed/NCBI
|
|
38
|
Chan AO and Rashid A: CpG island
methylation in precursors of gastrointestinal malignancies. Curr
Mol Med. 6:401–408. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li FF, Song SJ and Zhang RN:
Phosphatidylethanolamine-binding protein (PEBP) in basic and
clinical study. Sheng Li Ke Xue Jin Zhan. 40:214–218. 2009.(In
Chinese). PubMed/NCBI
|
|
40
|
Al-Mulla F, Hagan S, Al-Ali W, Jacob SP,
Behbehani AI, Bitar MS, Dallol A and Kolch W: Raf kinase inhibitor
protein: Mechanism of loss of expression and association with
genomic instability. J Clin Pathol. 61:524–529. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Eves EM, Shapiro P, Naik K, Klein UR,
Trakul N and Rosner MR: Raf kinase inhibitory protein regulates
aurora B kinase and the spindle checkpoint. Mol Cell. 23:561–574.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Martinho O, Gouveia A, Silva P, Pimenta A,
Reis RM and Lopes JM: Loss of RKIP expression is associated with
poor survival in GISTs. Virchows Arch. 455:277–284. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Licchesi JD and Herman JG:
Methylation-specific PCR. Methods Mol Biol. 507:305–323. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bird A: Molecular biology. Methylation
talk between histones and DNA. Science. 294:2113–2115. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Minoo P, Zlobec I, Baker K, Tornillo L,
Terracciano L, Jass JR and Lugli A: Loss of raf-1 kinase inhibitor
protein expression is associated with tumor progression and
metastasis in colorectal cancer. Am J Clin Pathol. 127:820–827.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hagan S, Al-Mulla F, Mallon E, Oien K,
Ferrier R, Gusterson B, García JJ and Kolch W: Reduction of Raf-1
kinase inhibitor protein expression correlates with breast cancer
metastasis. Clin Cancer Res. 11:7392–7397. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Schuierer MM, Bataille F, Hagan S, Kolch W
and Bosserhoff AK: Reduction in Raf kinase inhibitor protein
expression is associated with increased Ras-extracellular
signal-regulated kinase signaling in melanoma cell lines. Cancer
Res. 64:5186–5192. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R,
Rhodes D, Keller PJ, Mizokami A, Dunn R, Chinnaiyan AM, et al:
Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a
novel prognostic marker in prostate cancer. Prostate. 66:248–256.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Schuierer MM, Bataille F, Weiss TS,
Hellerbrand C and Bosserhoff AK: Raf kinase inhibitor protein is
downregulated in hepatocellular carcinoma. Oncol Rep. 16:451–456.
2006.PubMed/NCBI
|
|
50
|
Keller ET, Fu Z, Yeung K and Brennan M:
Raf kinase inhibitor protein: A prostate cancer metastasis
suppressor gene. Cancer Lett. 207:131–137. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Keller ET: Metastasis suppressor genes: A
role for raf kinase inhibitor protein (RKIP). Anticancer Drugs.
15:663–669. 2004. View Article : Google Scholar : PubMed/NCBI
|
